Cite
HARVARD Citation
Kim, S. et al. (2019). A tumor‐targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti‐PD‐1 immunotherapy in mouse models of glioblastoma. International journal of cancer. 145 (9), pp. 2535-2546. [Online].